XML 104 R41.htm IDEA: XBRL DOCUMENT v3.20.1
Other Intangible Assets (Tables)
 3 Months Ended
Mar. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]  
Other Intangible Assets
(In millions)
March 31, 2020
December 31, 2019
March 31, 2019
 
Gross
Accumulated
Amortization
Net
Gross
Accumulated
Amortization
Net
Gross
Accumulated
Amortization
Net
Intangible assets subject to amortization (Definite-lived):
 

 

 

 

 

 

 
 
 
Germplasm1
$
6,265

$
(126
)
$
6,139

$
6,265

$
(63
)
$
6,202

 
 
 
Customer-related
1,956

(293
)
1,663

1,977

(268
)
1,709

$
1,977

$
(182
)
$
1,795

Developed technology
1,463

(409
)
1,054

1,463

(370
)
1,093

1,411

(202
)
1,209

Trademarks/trade names
166

(88
)
78

166

(86
)
80

172

(86
)
86

Favorable supply contracts
475

(231
)
244

475

(207
)
268

475

(135
)
340

Other2
400

(218
)
182

404

(213
)
191

530

(289
)
241

Total other intangible assets with finite lives
10,725

(1,365
)
9,360

10,750

(1,207
)
9,543

4,565

(894
)
3,671

 
 
 
 
 
 
 
 
 
 
Intangible assets not subject to amortization (Indefinite-lived):
 

 

 

 

 

 

 
 
 
IPR&D
10

—

10

10

—

10

146

—

146

Germplasm1
 
 
 
 
 
 
6,265

—

6,265

Trademarks / trade names
1,871

—

1,871

1,871

—

1,871

1,871

—

1,871

Other
—

—

—

—

—

—

8

—

8

Total other intangible assets
1,881

—

1,881

1,881

—

1,881

8,290

—

8,290

Total
$
12,606

$
(1,365
)
$
11,241

$
12,631

$
(1,207
)
$
11,424

$
12,855

$
(894
)
$
11,961


1. 
Beginning on October 1, 2019, the company changed its indefinite life assertion of the germplasm assets to definite lived with a useful life of 25 years.  This change is the result of a more focused development effort of new seed products coupled with an intent to out license select germplasm on a non-exclusive basis. Prior to changing the useful life of the germplasm assets, the company tested the assets for impairment under ASC 350 - Intangibles, Goodwill and Other, concluding the assets were not impaired.
2. 
Primarily consists of sales and farmer networks, marketing and manufacturing alliances and noncompetition agreements.